Pipeline

Pipeline

Drug Development Pipeline

BCT-100

Pegylated recombinant human arginase 1, is a urea cycle enzyme of 329 amino acid residues. It is being developed for arginine depletion therapy in arginine auxotrophic cancers and multiple autoimmune disorders.

 

BCT-200

BCT-200 is modified from BCT-100 to maximize drug stability and safety.